ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselLonza Group AG
Lonza Group AG Logo
Verified· 4 sources

Lonza Group AG

Summary

About the company

Lonza Group AG is a CDMO company serving the healthcare industry, providing development and manufacturing services for biologics, small molecules and specialized modalities. The company supports customers with integrated offerings from early development through commercial production, as well as regulatory services.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered6
Biologics Development and Manufacturing
Biologics development and manufacturing from early development through cell line and process development to analytical services, drug substance and drug product manufacturing, and regulatory support.
Small Molecules Development and Manufacturing
Small molecule development and manufacturing with drug substance, drug product and CMC services, including early-phase development, commercial API production, bioavailability enhancement and regulatory support.
Bioconjugate Development and Manufacturing
Bioconjugate development and manufacturing for ADCs and other bioconjugates, with early development, process development, analytics, drug substance manufacturing, and clinical and commercial production.
mRNA and Lipid Nanoparticle Services
mRNA and lipid nanoparticle services with process development, analytics, mRNA manufacturing and lipid nanoparticle encapsulation for development and manufacture of related products.
Cell and Gene Therapy Services
Cell and gene therapy services with process development, cGMP manufacturing, and support for allogeneic, autologous, viral vectors and exosomes.
Microbial Development and Manufacturing
Microbial development and manufacturing with strain development, process development and optimization, drug substance manufacturing and analytical services.
Reviews

Aggregated rating

Aggregated rating
4.6
of 5

Aggregated from 5 reviews across all connected sources

Sources
GGoogle4.65
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

July 1, 2026Media
Swiss pharma firm Lonza expands partnership with US client
swissinfo.ch
March 10, 2026Media
Interview mit Lonza-CEO Wolfgang Wienand: «Jetzt gehen wir in die Offensive»
fuw.ch

Knowledge

No knowledge articles yet

Once Lonza Group AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Lonza Group AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Lonza Group AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Lonza Group AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Münchensteinerstrasse 38
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-106.841.866
Founded
2002 · 24 years
Last commercial register change
June 22, 2026
Employees
101 to 500

Similar companies

MS
Moderna Switzerland GmbH
Basel
PF
Pierre Fabre (Suisse) S.A.
Basel
RS
Regeneron Switzerland GmbH
Basel
EA
EsoCap AG
Basel
CA
Celonic AG
Basel
GS
Genevant Sciences GmbH
Basel
CP
Corden Pharma International Switzerland GmbH
Basel
UG
Umlaut.bio GmbH
Basel